Susquehanna International Group
ADPT icon

Susquehanna International Group’s Adaptive Biotechnologies ADPT Stock Holding History

Susquehanna International Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Sell
11,500
-9,500
-45% -$151K ﹤0.01% 11936
2025
Q4 		$341K Sell
21,000
-12,300
-37% -$201K ﹤0.01% 9644
2025
Q3 		$498K Buy
33,300
+8,100
+32% +$98.7K ﹤0.01% 8958
2025
Q2 		$294K Sell
25,200
-4,000
-14% -$36.3K ﹤0.01% 10383
2025
Q1 		$217K Buy
29,200
+10,500
+56% +$80.7K ﹤0.01% 10778
2024
Q4 		$112K Buy
+18,700
New +$103K ﹤0.01% 11245
2024
Q2 		– Sell
-20,700
Closed -$66.4K – 11931
2024
Q1 		$66.4K Buy
20,700
+3,800
+22% +$14.7K ﹤0.01% 11437
2023
Q4 		$82.8K Sell
16,900
-5,700
-25% -$26K ﹤0.01% 11455
2023
Q3 		$123K Sell
22,600
-37,500
-62% -$248K ﹤0.01% 10747
2023
Q2 		$403K Buy
60,100
+48,800
+432% +$363K ﹤0.01% 8813
2023
Q1 		$99.8K Sell
11,300
-8,200
-42% -$72.3K ﹤0.01% 11303
2022
Q4 		$149K Sell
19,500
-16,200
-45% -$126K ﹤0.01% 10498
2022
Q3 		$254K Buy
+35,700
New +$336K ﹤0.01% 10231
2022
Q2 		– Sell
-25,300
Closed -$351K – 12777
2022
Q1 		$351K Buy
25,300
+10,900
+76% +$171K ﹤0.01% 9879
2021
Q4 		$404K Sell
14,400
-16,100
-53% -$493K ﹤0.01% 9740
2021
Q3 		$1.04M Sell
30,500
-12,000
-28% -$434K ﹤0.01% 7463
2021
Q2 		$1.74M Sell
42,500
-23,300
-35% -$906K ﹤0.01% 6254
2021
Q1 		$2.65M Buy
65,800
+43,100
+190% +$2.33M ﹤0.01% 5243
2020
Q4 		$1.34M Sell
22,700
-32,400
-59% -$1.67M ﹤0.01% 5999
2020
Q3 		$2.68M Sell
55,100
-24,200
-31% -$1.02M ﹤0.01% 4070
2020
Q2 		$3.84M Sell
79,300
-45,800
-37% -$1.67M ﹤0.01% 3392
2020
Q1 		$3.48M Sell
125,100
-27,600
-18% -$770K ﹤0.01% 3067
2019
Q4 		$4.57M Buy
152,700
+67,700
+80% +$1.94M ﹤0.01% 3091
2019
Q3 		$2.63M Buy
+85,000
New +$3.47M ﹤0.01% 3717

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's ADPT Position: Q1 2026 in Review

Susquehanna International Group increased its Adaptive Biotechnologies (ADPT) stake by 329% in Q1 2026, buying an estimated $1.93M and bringing the position to 157,817 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #5968.

Susquehanna International Group first reported a position in ADPT in Q3 2019 and has held it in 26 quarters since. The position peaked at $4.03M in Q2 2020. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Susquehanna International Group held 157,817 shares of Adaptive Biotechnologies worth $2.19M as of Q1 2026.
  • Susquehanna International Group bought 121,002 Adaptive Biotechnologies shares in Q1 2026, an estimated $1.93M.
  • Adaptive Biotechnologies made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5968 holding.
  • Susquehanna International Group first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 26 quarters since.
  • Susquehanna International Group's Adaptive Biotechnologies position peaked at $4.03M in Q2 2020.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.